NASDAQ NMS - GLOBAL MARKET · ATYR
+3.75% · +$0.0188 · Vol 690.2K
Market closed · last close 4:00 PM ET · price as of 19:59:00 ET
aTyr Pharma Inc

aTyr Pharma Inc

Biotechnology
$0.5203
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
ATYR
aTyr Pharma Inc
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

49/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ATYR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ATYR catalysts
About aTyr Pharma Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2015
Employees
58
Country
US

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.5106
Day high
$0.5340
Day low
$0.4900
Previous close
$0.5015
52W high
$6.03
-91.37% from high
52W low
$0.3959
2% of range
Market cap
$49.2M
EPS
$-0.7000
Beta
2.63
Shares out
98.1M
Volume
690.2K
0.75× rel vol
Avg volume
924.2K
VWAP
$0.5128
Price history computed in-house
1W
+3.21%
1M
+9.93%
3M
+8.80%
1Y
-89.92%
YTD
-33.56%
SMA 50 $0.5212 · below
SMA 200 $0.7065 · below
52W position 2%

ATYR overview

Veridion Score
49
Registered · 2026-08-24
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ATYR.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ATYR Form 4 filings
Public disclosures

Congress activity in ATYR

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ATYR in the cached public ledger.

Federal contracts

ATYR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ATYR in this window.
Lobbying spend

ATYR lobbying filings, year to date.

Registered lobbying filings matched to aTyr Pharma Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ATYR in this window.
Loading news for ATYR
Analyst ratings
Sovereign unlock shows live analyst consensus for ATYR.
Options
Sovereign unlock shows live options positioning for ATYR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.